Addus HomeCare (ADUS) PT Lowered to $112 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- US stock futures rise as investors assess Democrats' midterm sweep
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ADUS Hot Sheet
Price: $126.55 --0%
Rating Summary:
15 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Rating Summary:
15 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Join SI Premium – FREE
Barclays analyst Andrew Mok lowered the price target on Addus HomeCare (NASDAQ: ADUS) to $112.00 (from $117.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Addus HomeCare (ADUS) PT Raised to $101 at Barclays
- Teva Pharma (TEVA) PT Raised to $54 at H.C. Wainwright
- Duolingo Inc. (DUOL) PT Raised to $155 at Wedbush
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
